Show simple item record

dc.contributor.authorCavadino, Alana
dc.date.accessioned2018-02-28T12:29:58Z
dc.date.available2018-02-28T12:29:58Z
dc.date.issued05/02/2018
dc.date.submitted2018-02-27T12:55:22.198Z
dc.identifier.citationCavadinoi, A. 2018. Hierarchical models in the analysis of trends in prevalence of congenital anomalies and risks associated with first trimester medications. Queen Mary University of Londonen_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/33946
dc.descriptionPhDen_US
dc.description.abstractAbstract Background Early identification of risk factors, in particular first trimester teratogenic medications, for congenital anomalies (CAs) is essential. Despite similarities between different CAs and between different medications, current surveillance methods in Europe examine each CA and each medication separately. This thesis aims to investigate whether the use of hierarchical statistical methods combining information in groups can improve CA surveillance methods. Methods EUROCAT is a European network of population-based CA registries, with EUROmediCAT comprising those registries with additional information on medication use in pregnancy. Trends in CAs from 2003-2012 in 18 EUROCAT registries (n=81,147) were analysed using Poisson regression models considering each CA separately and using hierarchical models combining related subgroups. First trimester medication exposures from 1995-2011 in 13 EUROmediCAT registries (n=15,058) were analysed. Firstly, groupings of medications and/or CAs were considered when determining the statistical significance of each medication-CA combination, using False Discovery Rate (FDR) procedures to adjust for multiple testing. Secondly, Bayesian hierarchical models were applied to directly model the group effects. The Australian classification system for prescribing medicines in pregnancy was used to independently identify “high risk” medications. The number of “high risk” medications identified by the FDR methods and Bayesian models were compared. Results For analysis of trends, grouping EUROCAT CA subgroups using hierarchical models did not provide additional information over that obtained from independent analyses of each subgroup. The double FDR method grouping medications by ATC3 level codes performed better than other FDR methods. Use of Bayesian hierarchical models did not produce enough of an improvement to justify the increased effort of implementing such models.en_US
dc.description.sponsorshipThis work was supported by the Medical Research Council [Award reference: 1504916] and the Wolfson Institute of Preventive Medicine.
dc.language.isoenen_US
dc.publisherQueen Mary University of London
dc.subjectEngineeringen_US
dc.subjectSolidification technologyen_US
dc.subjectCarbonationen_US
dc.subjectWaste materials disposalen_US
dc.titleHierarchical models in the analysis of trends in prevalence of congenital anomalies and risks associated with first trimester medications.en_US
dc.typeThesisen_US
dc.rights.holderThe copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without the prior written consent of the author


Files in this item

Thumbnail

This item appears in the following Collection(s)

  • Theses [4209]
    Theses Awarded by Queen Mary University of London

Show simple item record